Efectos maternos y neonatales por la administración de hidralazina en infusión o en bolo para el manejo de preeclampsia severa
No hay miniatura disponible
Fecha
2018
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Carrera de Obstetricia
Resumen
Trastorno hipertensivo en el embarazo es una patología que al trascurrir del tiempo se la ha venido estudiando por la frecuencia de morbimortalidad que presenta. Este trastorno hipertensivo para un mejor estudio se lo clasifico de la siguiente manera: preeclampsia y eclampsia - Hipertensión gestacional - Hipertensión crónica con preeclampsia sobre añadida - Hipertensión crónica. Enfocándonos en el tema podríamos decir que la preeclampsia severa es un trastorno hipertensivo que se presenta en mujeres gestantes a partir de las 20 semanas en adelante (segundo trimestre) va acompañado de edema, proteinuria, presión arterial de 160/110mmHg. El tratamiento de este trastorno hipertensivo es la Hidralazina por ser un fármaco de grandes bondades. En el presente trabajo de investigación demostramos cuales son los efectos que causa la administración de hidralazina en pacientes con diagnóstico de preeclampsia severa. Mi objetivo al realizar el trabajo de Titulación es dar a conocer los efectos secundarios que causa en la madre y el feto. En el trabajo de titulación se realizó un estudios descriptivo, retrospectivo; el cual se obtuvo información por medio de distintas historias clínicas recolectadas del área de estadística con el diagnóstico de preeclampsia severa tratadas con hidralazina en el área de emergencia ginecológica del Hospital Universitario ubicado en la provincia del Guayas cantón Guayaquil con un periodo de estudio el cual va desde el mes Mayo a Diciembre del año 2017. En conclusión en los estudios de la administración de hidralazina no se evidenciaron trastornos secundarios severos en la paciente a más de presentar cefaleas, vómitos, nauseas, taquicardia y en el neonato un apgar bajo al minuto de vida
Hypertensive disorder in pregnancy is a pathology that over time has been studied by the frequency of morbidity and mortality that presents. This hypertensive disorder for a better study is classified as follows: preeclampsia and eclampsia - Gestational hypertension - Chronic hypertension with preeclampsia on top - Chronic hypertension. Focusing on the subject we could say that severe preeclampsia is a hypertensive disorder that occurs in pregnant women from 20 weeks onwards (second trimester) is accompanied by edema, proteinuria, blood pressure of 160 / 110mmHg. The treatment of this hypertensive disorder is Hydralazine because it is a drug of great benefits. In the present work of investigation we demonstrate what are the effects caused by the administration of hydralazine in patients diagnosed with severe preeclampsia. The objective of the realization of this Titration Work is to publicize the secondary effects it causes in the mother and the fetus. In this project a descriptive, retrospective study was carried out; which information was obtained by means of different clinical histories collected from the area of statistics with the diagnosis of severe preeclampsia treated with hydralazine in the gynecological emergency area of the university hospital located in the province of Guayas Guayaquil canton with a period of study ranging from the month of May to the month of December. In short, the administration of hydralazine not severe secondary disorders in the patient more than presenting headache, vomiting, nausea, tachycardia and in the neonate a low apgar at minute of life.
Hypertensive disorder in pregnancy is a pathology that over time has been studied by the frequency of morbidity and mortality that presents. This hypertensive disorder for a better study is classified as follows: preeclampsia and eclampsia - Gestational hypertension - Chronic hypertension with preeclampsia on top - Chronic hypertension. Focusing on the subject we could say that severe preeclampsia is a hypertensive disorder that occurs in pregnant women from 20 weeks onwards (second trimester) is accompanied by edema, proteinuria, blood pressure of 160 / 110mmHg. The treatment of this hypertensive disorder is Hydralazine because it is a drug of great benefits. In the present work of investigation we demonstrate what are the effects caused by the administration of hydralazine in patients diagnosed with severe preeclampsia. The objective of the realization of this Titration Work is to publicize the secondary effects it causes in the mother and the fetus. In this project a descriptive, retrospective study was carried out; which information was obtained by means of different clinical histories collected from the area of statistics with the diagnosis of severe preeclampsia treated with hydralazine in the gynecological emergency area of the university hospital located in the province of Guayas Guayaquil canton with a period of study ranging from the month of May to the month of December. In short, the administration of hydralazine not severe secondary disorders in the patient more than presenting headache, vomiting, nausea, tachycardia and in the neonate a low apgar at minute of life.
Descripción
PDF
Palabras clave
Embarazo, Preeclampsia, Hidralazina, Hospital Universitario de Guayaquil, Cantón Guayaquil, Ecuador